Articles related to BREAST CANCER

Recent findings indicate that pre-WBRT administration of bevacizumab, etoposide, and cisplatin (BEEP) may significantly improve brain-specific progression-free survival in breast cancer patients with brain metastases.

Explore how metixene, a repositioned antiparkinsonian drug, emerges as a promising agent in treating metastatic breast cancer and brain metastases, redefining therapeutic approaches in oncology.

Highlighting a paradigm shift in breast cancer treatment, the NRG Oncology/NSABP B-51/RTOG 1304 study demonstrates that certain patients with node-negative breast cancer post-neoadjuvant chemotherapy may safely omit adjuvant regional nodal irradiation, challenging conventional treatment approaches and potentially improving patient quality of life.

Explore the latest findings from SABCS 2023 on the role of fusion RNAs in therapy resistance and the impact of new investigational therapies on metastatic breast cancer treatment.

AI’s transformative role in breast cancer care goes beyond prediction—it offers a nuanced evaluation of both cancerous and non-cancerous elements, guiding individualized treatment plans. Learn how this innovation minimizes unnecessary chemotherapy, prioritizes patient outcomes, and heralds a new era in precision medicine.

In a recent study, researchers found that vaginal estrogen therapy does not increase the risk of death in patients with breast cancer. In fact, it may even decrease the risk of breast cancer-specific death and all-cause death.